As of January 2026 Monopar Therapeutics has a market cap of NZ$0.81 Billion. This makes Monopar Therapeutics the world's 7311th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 21st, 2026 the market cap of Monopar Therapeutics was reported to be: